The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development

被引：8
|
作者：
Yu, Xiang-Qing [1 ]
Wilson, Alan G. E. [1 ]
机构：
[1] Lexicon Pharmaceut Inc, Drug Metab Pharmacokinet Toxicol & Pathol, The Woodlands, TX 77381 USA
来源：
FUTURE MEDICINAL CHEMISTRY | 2010年 / 2卷 / 06期
关键词：
VITRO METABOLISM DATA; SYSTEMS BIOLOGY; PHASE-0; TRIALS; IN-SILICO; BIOMARKERS; PREDICTION; SIMULATION; PARAMETERS; PHARMACOLOGY; DISPOSITION;
D O I：
10.4155/FMC.10.181
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
In silico and computational modeling, in conjunction with early absorption, distribution, metabolism and excretion/pharmacokinetic screening and pharmacokinetic/pharmacodyanmic modeling and simulation, will play an increasingly important role in optimizing drug discovery and development in the future.
引用
收藏
页码：923 / 928
页数：6
相关论文
共 50 条
  • [1] Biomarkers and biomeasures: key enablers for pharmacokinetic-pharmacodynamic modeling in drug discovery and development
    Agoram, Balaji M.
    van der Graaf, Piet H.
    BIOANALYSIS, 2012, 4 (10) : 1143 - 1145
  • [2] Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development
    Van der Graaf, Piet H.
    Gabrielsson, Johan
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (08) : 1371 - 1374
  • [3] Pharmacokinetic/Pharmacodynamic-Driven Drug Development
    Gallo, James M.
    MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (04): : 381 - 388
  • [4] Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective
    Jones, H. M.
    Chen, Y.
    Gibson, C.
    Heimbach, T.
    Parrott, N.
    Peters, S. A.
    Snoeys, J.
    Upreti, V. V.
    Zheng, M.
    Hall, S. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (03) : 247 - 262
  • [5] Pharmacodynamic and pharmacokinetic drug interactions
    Pleuvry, Barbara J.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2005, 6 (04) : 129 - +
  • [6] Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development
    Rioux, Nathalie
    Waters, Nigel J.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (07) : 934 - 943
  • [7] Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development
    Sarker, Debashis
    Pacey, Simon
    Workman, Paul
    BIOMARKERS IN MEDICINE, 2007, 1 (03) : 399 - 417
  • [8] Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development
    Singh, Aman P.
    Shin, Young G.
    Shah, Dhaval K.
    PHARMACEUTICAL RESEARCH, 2015, 32 (11) : 3508 - 3525
  • [9] Pharmacokinetic pharmacodynamic modeling of analgesics and sedatives in children
    Bardol, Maddlie
    Pan, Shan
    Walker, Suellen M.
    Standing, Joseph F.
    Dawes, Joy M.
    PEDIATRIC ANESTHESIA, 2023, 33 (10) : 781 - 792
  • [10] Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps
    Block, Michael
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (05) : 743 - 756
12345